Identifying intravenous immunoglobulin-resistant patients is essential for the prompt and optimal treatment of Kawasaki disease. suggesting the need for effective risk assessment tools. Data-driven approaches have the potential to identify the high-risk individuals by capturing the complex patterns of real-world data. To enable clinically applicable prediction of intravenous immunoglo... https://parisnaturalfoodes.shop/product-category/ohm-facial-cream/